[Federal Register Volume 78, Number 249 (Friday, December 27, 2013)]
[Notices]
[Pages 79018-79019]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-31026]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Request for a License To Export Deuterium

    Pursuant to 10 CFR 110.70 (b) ``Public Notice of Receipt of an 
Application,'' please take notice that the U.S. Nuclear Regulatory 
Commission (NRC) has received the following request for an export 
license. Copies of the request are available electronically through 
ADAMS and can be accessed through the Public Electronic Reading Room 
(PERR) link http://www.nrc.gov/reading-rm.html at the NRC Homepage.
    A request for a hearing or petition for leave to intervene may be 
filed within thirty days after publication of this notice in the 
Federal Register. Any request for hearing or petition for leave to 
intervene shall be served by the requestor or petitioner upon the 
applicant, the Office of the General Counsel, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555; the Office of Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555; and the Executive 
Secretary, U.S. Department of State, Washington, DC 20520.
    A request for a hearing or petition for leave to intervene may be 
filed with the NRC electronically in accordance with NRC's E-Filing 
rule promulgated in August 2007, 72 FR 49139 (Aug. 28, 2007). 
Information about filing electronically is available on the NRC's 
public Web site at http://www.nrc.gov/site-help/e-submittals.html. To 
ensure timely electronic filing, at least 5 (five) days prior to the 
filing deadline, the petitioner/requestor should contact the Office of 
the Secretary by email at [email protected], or by calling (301) 
415-1677, to request a digital ID certificate and allow for the 
creation of an electronic docket.
    In addition to a request for hearing or petition for leave to 
intervene, written comments, in accordance with 10 CFR 110.81, should 
be submitted within thirty (30) days after publication of this notice 
in the Federal Register to Office of the Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555, Attention: Rulemaking and 
Adjudications.
    The information concerning this export license application follows.

[[Page 79019]]



                                         NRC Export License Application
                                            [Description of material]
----------------------------------------------------------------------------------------------------------------
   Name of applicant,  date of
  application,  date received,       Material type      Total quantity          End use        Recipient country
  application no.,  docket no.
----------------------------------------------------------------------------------------------------------------
Concert Pharmaceuticals, Inc....  Heavy water (D2O).  ~20,000.0 kgs.....  Non-nuclear end-    Portugal, Austria
August 29, 2013.................                                           use in active
December 5, 2013................                                           pharmaceutical
XMAT431.........................                                           ingredient
11006131........................                                           manufacturing..
----------------------------------------------------------------------------------------------------------------


     Dated this 20th day of December 2013 in Rockville, Maryland.
    For the Nuclear Regulatory Commission.

Stephen Dembek,
Acting Deputy Director, Office of International Programs.
[FR Doc. 2013-31026 Filed 12-26-13; 8:45 am]
BILLING CODE 7590-01-P